Fox Run Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Fox Run Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Buy	+6,422	New	+$214K	0.04%	790
2024 Q2	–	Sell	-43,333	Closed	-$611K	–	1074
2024 Q1	$611K	Sell	43,333 -3,263	-7%	-$41.1K	0.13%	295
2023 Q4	$486K	Buy	+46,596	New	+$435K	0.12%	307
2023 Q2	–	Sell	-41,299	Closed	-$365K	–	954
2023 Q1	$365K	Buy	+41,299	New	+$408K	0.12%	341
2022 Q3	–	Sell	-23,001	Closed	-$173K	–	820
2022 Q2	$173K	Buy	+23,001	New	+$200K	0.09%	428
2020 Q4	–	Sell	-10,646	Closed	-$96K	–	288
2020 Q3	$96K	Buy	+10,646	New	+$113K	0.24%	146
2020 Q1	–	Sell	-30,174	Closed	-$296K	–	351
2019 Q4	$296K	Buy	+30,174	New	+$269K	0.24%	204
2019 Q2	–	Sell	-16,205	Closed	-$254K	–	619
2019 Q1	$254K	Buy	16,205 +1,418	+10%	+$25K	0.14%	320
2018 Q4	$228K	Buy	+14,787	New	+$303K	0.12%	367
2018 Q3	–	Sell	-33,600	Closed	-$817K	–	816
2018 Q2	$817K	Buy	33,600 +22,784	+211%	+$465K	0.26%	80
2018 Q1	$185K	Buy	+10,816	New	+$211K	0.04%	643
2017 Q2	–	Sell	-27,500	Closed	-$882K	–	830
2017 Q1	$882K	Buy	+27,500	New	+$938K	0.36%	40
2016 Q3	–	Sell	-4,400	Closed	-$221K	–	689
2016 Q2	$221K	Buy	+4,400	New	+$234K	0.11%	399

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Fox Run Management's TEVA Position: Q2 2026 in Review

Fox Run Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 6,422 shares worth $218K. The stake represents 0.04% of the portfolio and ranks #790 among its holdings. This is a return to the name: Fox Run Management previously reported a position in TEVA as recently as Q1 2024.

Fox Run Management first reported a position in TEVA in Q2 2016 and has held it in 13 quarters since. The position peaked at $882K in Q1 2017. 679 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Fox Run Management held 6,422 shares of Teva Pharmaceutical Industries Limited worth $218K as of Q2 2026.
Teva Pharmaceutical Industries Limited was a new Fox Run Management position in Q2 2026.
Teva Pharmaceutical Industries Limited made up 0.04% of Fox Run Management's portfolio in Q2 2026, its #790 holding.
Fox Run Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and has held it in 13 quarters since.
Fox Run Management's Teva Pharmaceutical Industries Limited position peaked at $882K in Q1 2017.
679 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.